微信直播

Prof. Arie Pieter Kapptein:欧洲经导管主动脉瓣置换术经验分享

Published at: 2015年第1卷第S1期

周丽桃
关键词:

编者按:经导管主动脉瓣置换术(TAVR)亦称为经导管主动脉瓣植入术(TAVI),这是心脏介入领域中的一项革命性的技术。早在2002年,经导管术在欧洲开始发展,至今已有10余年。在第24届亚洲心脏血管及胸腔外科学会(ASCVTS)暨第四届亚洲单孔胸腔镜论坛(ASPVS)上来自鹿特丹伊拉斯谟大学医学中心(Erasmus MC)的Arie Pieter Kapptein教授以“Lessons learned from the European TAVI experience clinical decision making in elderly patients”为题跟大家分享了欧洲治疗早期患者的经导管主动脉瓣置换手术的临床经验。AME编辑部很荣幸邀请到Kapptein教授接受我们的采访,进一步了解目前经导管主动脉瓣置换术的发展和挑战。

 

采访问题

  1. Could you make a brief summary of your speech for our readers who could not be no on site?

  2. How to select the surgical valve and the natural valve?

  3. What are the recent progresses of TAVR/TAVI?

  4. What are the challenges of TAVR/TAVI?

  5. How to train the young surgeons in the field of TAVR/TAVI?

  6. Why you choose to be a surgeon?

 

访谈视频

专家介绍

Prof. Arie Pieter Kapptein is the residency program director of Erasmus MC Rotterdam and a surgeon of cards-thoracic surgery. His research interests are coronary surgery, transcatheter valve implantation, valve surgery, education and thoracic surgery. Prof. Kapptein is member of many renowned professional societies, such as American Association for Thoracic Surgery. He has published more than 360 articles with about 16,000 citations.

 

采访编辑丨周丽桃,科学编辑,AME 出版社;

视频编辑丨麦雪芳,视频编辑,AME 出版社。

 

相关阅读:

 

doi:10.3978/kysj.2014.1.1878

comments powered by Disqus

附件